Should I buy, sell or hold TruAlt Bioenergy Ltd?

Based on the current situation of TruAlt Bioenergy Ltd, it would be advisable to consider selling your shares. The company is facing significant challenges, including a high debt level with a debt-to-equity ratio of 0, which indicates financial instability. Additionally, the company has reported losses, resulting in a negative return on capital employed (ROCE), which is concerning for long-term investors.Moreover, the recent performance shows a decline, with a profit after tax of Rs 31.39 crore reflecting a growth rate of -44.47% over the last six months. The fact that 36.85% of promoter shares are pledged adds further risk, especially in a declining market, as it can exert additional downward pressure on stock prices.While there are some attractive valuation metrics, such as a ROCE of 8.9 and a 1.7 enterprise value to capital employed, these positives may not outweigh the significant risks posed by the company's financial health and recent performance trends. Therefore, selling your shares might be the prudent choice at this time.

Which are the latest news on TruAlt Bioenergy?

TruAlt Bioenergy Gains 13.35%: 4 Key Factors Driving the Week’s Volatility TruAlt Bioenergy Ltd Hits Intraday High with 7.4% Surge on 6 Feb 2026

Why is TruAlt Bioenergy Ltd falling/rising?

As of 08-Feb, TruAlt Bioenergy Ltd's stock price is rising, currently at 431.80, with a change of 23.85 (5.85%) upward. This increase can be attributed to several factors. The stock has outperformed its sector by 8.2% today and has been on a consecutive gain streak for the last two days, accumulating a total return of 14.52% during this period. Additionally, the stock reached an intraday high of Rs 445, reflecting strong investor interest and activity.The stock's performance over the past week shows a significant increase of 13.35%, while it has also outperformed the benchmark Sensex, which only rose by 1.59% in the same timeframe. Year-to-date, TruAlt Bioenergy has shown a positive return of 6.82%, contrasting with a decline of 1.92% in the Sensex. Furthermore, the stock is trading above its moving averages across various timeframes, indicating a bullish trend.Investor participation appears to be rising, with a delivery volume of 2.08 lacs on 05 Feb, which is 2.74% higher than the five-day average. This suggests that more investors are willing to hold the stock, contributing to its upward momentum. Despite some concerns regarding high debt and pledged promoter shares, the stock's attractive valuation, indicated by a return on capital employed (ROCE) of 8.9 and a favorable enterprise value to capital employed ratio, supports its current price increase. Overall, the combination of strong recent performance, positive investor sentiment, and favorable trading conditions has led to the rise in TruAlt Bioenergy Ltd's stock price.

TRUALT Share Price | TruAlt Bioenergy Ltd Stock Analysis & Recommendation

Q: Are TruAlt Bioenergy Ltd latest results good or bad?

TruAlt Bioenergy Ltd's latest results present a mixed picture. On one hand, the company achieved a remarkable quarter-on-quarter revenue growth of 520.96%, reaching ₹713.24 crores, and returned to profitability with a net profit of ₹69.33 crores, marking a significant increase of 282.74% compared to the previous quarter. This indicates strong operational momentum and recovery in demand.However, the profitability metrics reveal concerning trends. The operating margin has compressed significantly from 30.01% in the same quarter last year to 18.79% this year, and the profit after tax (PAT) margin has also declined from 18.11% to 9.70%. This suggests that while the company is generating more revenue, it is struggling to maintain profitability due to rising costs or operational inefficiencies.Additionally, the year-on-year comparison shows a decline in net profit by 7.79%, which raises concerns about the sustainability of the recent growth. The company's elevated debt levels and weak interest coverage ratio further complicate its financial health.In summary, while the revenue growth is impressive and indicates a recovery, the significant margin compression and declining profitability metrics suggest that the results are not entirely favorable. Investors should be cautious and monitor how the company addresses these challenges moving forward.

Key Events This Week

2 Feb: Stock opens week at Rs.380.05 amid broad market weakness

3 Feb: Strong rebound with 6.33% gain to Rs.404.10

4 Feb: Intraday low hit at Rs.366.35 amid price pressure and margin concerns

5 Feb: Recovery with 6.63% gain to Rs.407.95 following stabilised quarterly results

6 Feb: Intraday high of Rs.445 and 7.4% surge closes week at Rs.431.80

Read full news article

TruAlt Bioenergy Ltd Hits Intraday High with 7.4% Surge on 6 Feb 2026

TruAlt Bioenergy Ltd recorded a robust intraday performance on 6 Feb 2026, surging 7.4% to touch a day’s high of Rs 445, significantly outperforming the Commodity Chemicals sector and broader market indices.

Read full news article

Are TruAlt Bioenergy Ltd latest results good or bad?

TruAlt Bioenergy Ltd's latest financial results for Q3 FY26 present a complex picture of operational performance. The company achieved a notable revenue growth of 520.96% quarter-on-quarter, reaching ₹713.24 crores, which reflects a strong recovery in demand within the commodity chemicals sector. Year-on-year, revenue also grew by 71.82%, indicating a positive trend in sales performance compared to the previous year. However, this significant top-line growth did not translate into proportional profitability. The net profit for the quarter was reported at ₹69.33 crores, which, while representing a substantial quarter-on-quarter increase of 282.74%, showed a decline of 7.79% compared to the same quarter last year. This suggests that despite higher sales, the company's ability to convert revenue into profit has weakened. The operating margin for TruAlt Bioenergy has come under pressure, decreasing to 18.79% ...

Read full news article

[ { "link": "quarterly", "btn_text": "All Quarterly Results", "header": "Quarterly Results Snapshot (Standalone) - Dec'25 - QoQ", "rhs": [ { "prefix": "Net Sales ", "suffix": "QoQ Growth in quarter ended Dec 2025 is 572.88% vs -64.45% in Sep 2025", "dir": 1 }, { "prefix": "Standalone Net Profit ", "suffix": "QoQ Growth in quarter ended Dec 2025 is 254.43% vs -1,42,600.00% in Sep 2025", "dir": 1 } ], "table": { "header": [ "Dec'25", "Sep'25", "Change(%)" ], "body": [ { "field": "Net Sales", "val1": "703.02", "val2": "104.48", "chgp": "572.88%", "chgp_class": "positive" }, { "field": "Operating Profit (PBDIT) excl Other Income", "val1": "129.05", "val2": "-11.79", "chgp": "1,194.57%", "chgp_class": "positive" }, { "field": "Interest", "val1": "39.65", "val2": "38.01", "chgp": "4.31%", "chgp_class": "negative" }, { "field": "Exceptional Items", "val1": "0.00", "val2": "0.00", "chgp": "", "chgp_class": "neutral" }, { "field": "Standalone Net Profit", "val1": "66.02", "val2": "-42.75", "chgp": "254.43%", "chgp_class": "positive" }, { "field": "Operating Profit Margin (Excl OI)", "val1": "18.36%", "val2": "-11.28%", "chgp": "29.64%", "chgp_class": "positive" } ] } }, { "link": "half-yearly", "btn_text": "All Half Yearly Results", "header": "Half Yearly Results Snapshot (Standalone) - Sep'25", "rhs": [ { "prefix": "Net Sales ", "suffix": "Not Applicable: The company has declared_date for only one period", "dir": 0 }, { "prefix": "Standalone Net Profit ", "suffix": "Not Applicable: The company has declared_date for only one period", "dir": 0 } ], "table": { "header": [ "Sep'25", "Sep'24", "Change(%)" ], "body": [ { "field": "Net Sales", "val1": "398.41", "val2": "573.53", "chgp": "-30.53%", "chgp_class": "negative" }, { "field": "Operating Profit (PBDIT) excl Other Income", "val1": "23.10", "val2": "27.23", "chgp": "-15.17%", "chgp_class": "negative" }, { "field": "Interest", "val1": "75.26", "val2": "67.15", "chgp": "12.08%", "chgp_class": "negative" }, { "field": "Exceptional Items", "val1": "0.00", "val2": "0.00", "chgp": "", "chgp_class": "neutral" }, { "field": "Standalone Net Profit", "val1": "-42.72", "val2": "-41.99", "chgp": "-1.74%", "chgp_class": "negative" }, { "field": "Operating Profit Margin (Excl OI)", "val1": "5.80%", "val2": "4.75%", "chgp": "1.05%", "chgp_class": "positive" } ] } }, { "link": "nine-monthly", "btn_text": "All Nine Monthly Results", "header": "Nine Monthly Results Snapshot (Standalone) - Dec'25", "rhs": [ { "prefix": "Net Sales ", "suffix": "Not Applicable: The company has declared_date for only one period", "dir": 0 }, { "prefix": "Standalone Net Profit ", "suffix": "Not Applicable: The company has declared_date for only one period", "dir": 0 } ], "table": { "header": [ "Dec'25", "Dec'24", "Change(%)" ], "body": [ { "field": "Net Sales", "val1": "1,101.43", "val2": "980.84", "chgp": "12.29%", "chgp_class": "positive" }, { "field": "Operating Profit (PBDIT) excl Other Income", "val1": "152.15", "val2": "146.27", "chgp": "4.02%", "chgp_class": "positive" }, { "field": "Interest", "val1": "114.91", "val2": "102.57", "chgp": "12.03%", "chgp_class": "negative" }, { "field": "Exceptional Items", "val1": "0.00", "val2": "0.00", "chgp": "", "chgp_class": "neutral" }, { "field": "Standalone Net Profit", "val1": "23.30", "val2": "30.39", "chgp": "-23.33%", "chgp_class": "negative" }, { "field": "Operating Profit Margin (Excl OI)", "val1": "13.81%", "val2": "14.91%", "chgp": "-1.10%", "chgp_class": "negative" } ] } }, { "link": "annual", "btn_text": "All Annual Results", "header": "Annual Results Snapshot (Standalone) - Mar'25", "rhs": [ { "prefix": "Net Sales ", "suffix": "Not Applicable: The company has declared_date for only one period", "dir": 0 }, { "prefix": "Standalone Net Profit ", "suffix": "Not Applicable: The company has declared_date for only one period", "dir": 0 } ], "table": { "header": [ "Mar'25", "Mar'24", "Change(%)" ], "body": [ { "field": "Net Sales", "val1": "1,880.12", "val2": "1,223.40", "chgp": "53.68%", "chgp_class": "positive" }, { "field": "Operating Profit (PBDIT) excl Other Income", "val1": "297.20", "val2": "188.08", "chgp": "58.02%", "chgp_class": "positive" }, { "field": "Interest", "val1": "141.04", "val2": "143.08", "chgp": "-1.43%", "chgp_class": "positive" }, { "field": "Exceptional Items", "val1": "0.00", "val2": "0.00", "chgp": "", "chgp_class": "neutral" }, { "field": "Standalone Net Profit", "val1": "140.62", "val2": "31.81", "chgp": "342.06%", "chgp_class": "positive" }, { "field": "Operating Profit Margin (Excl OI)", "val1": "15.81%", "val2": "15.37%", "chgp": "0.44%", "chgp_class": "positive" } ] } } ]